Recently, CELLINK, based in Boston, launched the BIO X6 bioprinting platform. This six-printhead bioprinting platform enables users to combine more materials, cells and tools than other systems currently available on the market. In fact, the company specialises in designing and developing bioprinting technologies that enable to 3D print organs and tissue for applications in pharmaceuticals to cosmetics. They also offer a patent-pending bioink that allows human cells to grow and thrive as they would in their natural environment. Ultimately, the aim of the startup is to provide researchers with affordable bioprinting technology that can help to further their research. We spoke to CEO and Co-Founder Erik Gatenholm to learn more!